ClinicalTrials.Veeva

Menu

Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

R

Rambam Health Care Campus

Status

Withdrawn

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT00846560
ALS04CTIL

Details and patient eligibility

About

The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ALS patients who could sign ICF.

Exclusion criteria

  • No ALS patients age less than 18 years.

Trial design

0 participants in 2 patient groups

1 ALS patients
2 Healthy subjects

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems